- Home
- DRUG vs MEI Comparison
DRUG vs MEI Comparison
Compare DRUG & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- MEI
- Stock Information
- Founded
- DRUG 2019
- MEI 1946
- Country
- DRUG United States
- MEI United States
- Employees
- DRUG N/A
- MEI N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- MEI Electrical Products
- Sector
- DRUG Health Care
- MEI Technology
- Exchange
- DRUG Nasdaq
- MEI Nasdaq
- Market Cap
- DRUG 233.2M
- MEI 238.4M
- IPO Year
- DRUG N/A
- MEI N/A
- Fundamental
- Price
- DRUG $25.95
- MEI $7.95
- Analyst Decision
- DRUG Strong Buy
- MEI Buy
- Analyst Count
- DRUG 6
- MEI 2
- Target Price
- DRUG $83.25
- MEI $10.50
- AVG Volume (30 Days)
- DRUG 29.2K
- MEI 223.3K
- Earning Date
- DRUG 05-15-2025
- MEI 07-10-2025
- Dividend Yield
- DRUG N/A
- MEI 7.04%
- EPS Growth
- DRUG N/A
- MEI N/A
- EPS
- DRUG N/A
- MEI N/A
- Revenue
- DRUG N/A
- MEI $1,068,300,000.00
- Revenue This Year
- DRUG N/A
- MEI N/A
- Revenue Next Year
- DRUG N/A
- MEI $1.16
- P/E Ratio
- DRUG N/A
- MEI N/A
- Revenue Growth
- DRUG N/A
- MEI N/A
- 52 Week Low
- DRUG $0.93
- MEI $5.08
- 52 Week High
- DRUG $79.02
- MEI $17.45
- Technical
- Relative Strength Index (RSI)
- DRUG 30.05
- MEI 65.45
- Support Level
- DRUG $26.30
- MEI $7.72
- Resistance Level
- DRUG $31.20
- MEI $8.05
- Average True Range (ATR)
- DRUG 2.50
- MEI 0.26
- MACD
- DRUG -0.55
- MEI 0.05
- Stochastic Oscillator
- DRUG 5.59
- MEI 89.36
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About MEI Methode Electronics Inc.
Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.